Sam Goldberger
Syndicate lead · Newton Center, MA
Sam Goldberger is a syndicate lead based in Newton Center, MA focused on Biotech & Pharma, B2B Software, Healthcare, investing at seed, series a stage. Estimated typical check: $410K. Sam Goldberger's latest dated investing activity was in Oct 2024.
Why Sam Goldberger is listed
Named as one of two individuals (Managing Partner of the General Partner of the Issuer) on the Form D for Ambit SPV1 LP, a $410K venture SPV (Mar 2023). Also a non-executive director at 3 startups that filed Form D.
Source: SEC Form D: Ambit SPV1 LP (Mar 27, 2023) · 3 more sources
Is this you? Remove or correct this profile.
- Stages
- Seed, Series A
- Typical check (est.)
- $410K
- Latest fund
- SPVs only
- Latest dated activity
- Oct 2024
Is Sam Goldberger a fit for you?
See your fit score and the reason, contact details, and any warm path from your network.
What does Sam Goldberger invest in?
Biotech & PharmaB2B SoftwareHealthcareWhat has Sam Goldberger invested in recently?
- Oct 2024
Hubble Therapeutics
Board seat on the company's SEC filing (not by itself proof of an investment) · NH
- Aug 2023
SurgiBox
Board seat on the company's SEC filing (not by itself proof of an investment) · MA
- May 2023
Bone Health Technologies
Board seat on the company's SEC filing (not by itself proof of an investment) · CA
Funds and deal vehicles Sam Goldberger filed with the SEC
- Mar 2023
Ambit SPV1 LP
Deal vehicle · $410K offering
Sources
- SEC Form D: Ambit SPV1 LPMar 27, 2023
- SEC Form D (board seat): Bone Health TechnologiesMay 9, 2023
- SEC Form D (board seat): SurgiBoxAug 24, 2023
- SEC Form D (board seat): Hubble TherapeuticsOct 21, 2024
Data refreshed from public sources Oct 15, 2026. Is this you? Remove or correct this profile.